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Tumours develop in an evolutionary process, in which the accu-
mulation of mutations produces subpopulations of cells with distinct
mutational profiles, called clones. This process leads to the genetic
heterogeneity widely observed in tumour sequencing data, but iden-
tifying the genotypes and frequencies of the different clones is still a
major challenge. Here, we present Cloe, a phylogenetic latent feature
model to deconvolute tumour sequencing data into a set of related
genotypes. Our approach extends latent feature models by placing the
features as nodes in a latent tree. The resulting model can capture
both the acquisition and the loss of mutations, as well as episodes
of convergent evolution. We establish the validity of Cloe on syn-
thetic data and assess its performance on controlled biological data,
comparing our reconstructions to those of several published state-of-
the-art methods. We show that our method provides highly accurate
reconstructions and identifies the number of clones, their genotypes
and frequencies even at a modest sequencing depth. As a proof of con-
cept we apply our model to clinical data from three cases with chronic
lymphocytic leukaemia, and one case with acute myeloid leukaemia.
1. Introduction. Cancers evolve through waves of mutation and clonal
expansion [18]. Darwinian selection operates on the increased variation within
the tumour, favouring clones with increased fitness, according to microenvi-
ronmental and therapeutic pressures [5, 24, 1, 2]. As a consequence of this
evolutionary process, tumours are generally genetically heterogeneous [8, 17]
and consist of related populations of cancer cells (clones) with distinct geno-
types, which encode the evolutionary history of each cell population [17].
This genetic heterogeneity is important clinically because it can confound
the molecular profiling of biopsies, and increased variation may equip tu-
mours with more avenues to escape treatment, leading to worse progno-
sis [22].
The clonal deconvolution problem. Identifying clones and their proportions
is a difficult task [2], aggravated by the fact that cancer genomics data gener-
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ally come from bulk sequencing experiments, which profile a mixture of cells
from different clones. Clones are related to each other and can be thought
of as nodes in a phylogenetic tree that describes tumour development. The
root of the tree corresponds to a normal, non-mutated cell; every other node
is a cancer clone with a distinct complement of mutations (its genotype).
Each clone inherits the mutations of its parent and adds more to them. This
encodes a subset relationship between parent and child nodes.
However, none of this is directly observable. Instead, the data only consist
of a set of mutations and their proportions (called allele fractions) in a
collection of tumour samples (Figure 1). The clonal deconvolution problem
thus asks to identify the clonal genotypes, phylogeny, and clonal fractions
that best explain the observed data [4].
Additional challenges. The clonal deconvolution problem is further compli-
cated by factors such as the selection of alleles during tumour evolution and
the specifics of the data obtained from sequencing experiments. In particular,
convergent evolution and mutational loss contradict the common assump-
tion that mutations arise only once in the phylogeny (the infinite sites as-
sumption) and never disappear. Tumours are subjected to internal selective
pressures in their microenvironment and external pressures from therapeutic
interventions. In such cases, multiple tumour clones may acquire the same
mutation in convergent evolution, especially if it is a hotspot mutation or it
confers resistance to the treatment. At the same time, mutations can be re-
moved by several mechanisms, including loss of heterozygosity, the deletion
of the chromosome fragment carrying the mutation. Another challenge is
that for cost-effective sequencing options like targeted amplicon sequencing,
which we will use in the case studies, the depth of sequencing is not infor-
mative of the chromosomal copy-number of the tumour. This contradicts
assumptions often made by previous methods.
Previous approaches. Various methods have been proposed in the litera-
ture [2] to improve on manual analyses [8, 17]. To put our approach in con-
text, it is useful to distinguish direct reconstructions that directly infer clonal
genotypes (like CloneHD [6], Clomial [26] and BayClone [23]) from indirect
reconstructions that obtain clusters of mutations rather than full genotypes
and require additional phylogenetic analysis to obtain clonal genotypes (like
PyClone [19], SciClone [15], PhyloWGS [3], and BitPhylogeny [25]).
Direct reconstructions generally aim to infer two quantities, a matrix of
mutation assignments and a matrix of clonal fractions, which come together
in an admixture to form the sampling model. The mutation assignments
matrix associates each mutation with zero or more classes, which can be
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Fig 1. Overview of the general clonal deconvolution problem. Sample A shows how from a
normal root node, four clones evolved according to the displayed phylogeny. In this example,
genotypes consist of two loci (blue and orange), which may be mutated (red star), gained
or lost. The normal genotype consists of two non-mutated alleles for each locus. Clonal
fractions are represented by the diameter of the node and reported as a percentage. A second
sample B from the same patient would also consist of the same tree and genotypes; clonal
fractions, however, may change (as in this example). These latent parameters give rise
to the observed mutation and copy-number data, shown at the bottom. The allele fraction
of a mutation is the proportion of that allele in the sample. The observed copy-number is
the total copy number of each clone weighted by the clonal fractions. The increase of the
orange mutation’s allele fraction and the decrease of its observed copy-number are due to
the growth of the clone with a single mutated copy.
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intuitively interpreted as clonal genotypes. For models that lack a phylogeny,
inference may yield biologically implausible genotypes, as shown later in the
benchmarking studies (section 3.3).
On the other hand, indirect methods cluster mutations based on their
allele fractions across multiple samples. Joint phylogenetic modelling allows
these clusters to become nodes of a tree, displaying at which node each muta-
tion first appeared. Hence, the assignment of mutation clusters to nodes of a
tree is generally inflexible to episodes of convergent evolution or mutational
loss.
Latent feature models. Here we introduce Cloe, a phylogenetic latent fea-
ture model for clonal deconvolution that belongs to the category of direct
reconstruction methods. Latent feature models discover independent fea-
tures with which to describe a set of observed objects. The set of features
possessed by an object determines the parameters of its distribution [10]. In
our context, observed objects are mutations, and latent features are clonal
genotypes.
Latent feature models have been previously applied to clonal deconvolu-
tions, but maintained the assumption that features are independent [26, 23].
In parallel, extensions to these models have been developed to relate features
hierarchically, but placed features as the leaves of the tree [12]. Moreover,
these tree structure only correlated the feature assignments, making such a
model unsuitable for clonal deconvolutions.
The model we propose lifts the independence assumption and relates fea-
tures with a latent hierarchy. In our framework features live at every node
of the tree, thus encoding a noisy subset relationship in the mutation as-
signments. Our model differs from the phylogenetic Indian Buffet Process as
the latter relates observed objects with a latent phylogeny, rather than the
features [16]. Our approach is more general than previously published meth-
ods, because it relies on fewer assumptions on clones and the evolutionary
model: we can readily model multiple independent primary tumours, account
for loss of mutations and penalise, though still allow, convergent evolution.
We validate Cloe on simulated data, on a controlled biological dataset, and
apply it to two published clinical datasets: longitudinal samples from three
chronic lymphocytic leukaemia patients [21], and from an acute myeloid
leukaemia case [11]. Cloe is available as an R package at https://bitbucket.
org/fm361/cloe.
2. The Cloe model. Our model follows the overview of Figure 1. A
latent phylogenetic tree influences the clonal genotypes; these, together with
clonal fractions and additional nuisance parameters, describe the distribu-
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Fig 2. An outline of the graphical model corresponding to Cloe, omitting for simplicity
overlapping plates and convergent evolution relations. Legend: γ, clonal fractions hyperpa-
rameters; F, clonal fractions matrix; T , phylogeny; Z, genotypes matrix; X, mutant read
counts; D, depths; s, Beta-binomial overdispersion parameter.
tion of the data.
We observe data for J mutations in T samples, and the data are collected
in two J×T matrices: X for mutant read counts, and D for read depths, the
number of times a particular locus of the genome is covered by sequencing
reads.
The phylogenetic tree is defined by a vector T with K > 1 elements,
one for each clone. We consider the normal contamination as a fixed clone.
Our analysis is restricted to mutations in copy-number neutral regions: each
clone, including the normal, contributes exactly two copies of each allele, of
which at most one can be mutated. Clonal genotypes are defined in a binary
J ×K matrix Z, where each column z·k represents the genotype of clone k.
The proportions of each clone in each sample are summarised in a K × T
matrix F formed by T stochastic vectors.
Our goal is to infer the phylogeny T , clonal genotypes Z, and clonal
fractions F from the posterior distribution P (T ,Z,F |X,D). To do this, in
the following sections we develop a probabilistic model that links observed
and unobserved variables, and an inference algorithm to explore the posterior
distribution.
2.1. Model definition. For guidance, a simplified version of our model is
outlined in Figure 2, while at the end of this section Figure 3 presents the
complete model.
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Phylogeny. For K > 1 populations, we model the phylogenetic tree as a
vector T of length K, where Tk = l means that the parent of k is l. The
normal clone is fixed as the first entry, the root of the tree. To ensure that
the graph encoded by T is a tree, we let each entry only take values on the
previous entries. This definition is flexible as the tree can assume any shape,
even allowing phylogenies with multiple primary tumours. T is defined by
T1 = 0,
T2 = 1,
Tk ∼ U (δ, k − 1) for k ∈ {3 . . .K},
(2.1)
where U(δ, a) is a one-deflated discrete uniform distribution with values
in {1, . . . , a}. The probability of drawing a 1 is δ, and the probability of
drawing an integer between 2 and a is uniform:
U(x; δ, a) =
{
δ if x = 1
1−δ
a−1 if x ∈ {2, 3, . . . , a}
(2.2)
We penalise multiple independent primary tumours (multiple children of the
normal clone) by setting δ = (2k)−1.
Genotypes. Genotypes are defined in a binary J × K matrix Z = (zjk),
where 1 denotes a mutation and 0 the un-mutated (wildtype) state, for each
mutation j in each clone k. We fix the genotype of the normal clone to a zero
vector of length J , implying that all mutations are somatic. More generally,
the normal genotype could be modified to accommodate for known germline
variants. The genotype of a clone k for a mutation j is then defined as
(2.3) zjk | zjTk , µ, ρ ∼ Bernoulli(pjk)
where µ is the probability of mutating if the parent does not have a mutation,
and ρ is the probability of reverting to wildtype if the parent is mutated:
(2.4) pjk =
{
µ if zjTk = 0
1− ρ if zjTk = 1.
Clonal fractions. Because the samples may be collected latitudinally, lon-
gitudinally, and at irregular intervals, we assume that clonal fractions are
independent between samples. We represent clonal fractions with a K × T
matrix F = (f·t)t=1,...,T composed of a collation of stochastic column vectors
f·t describing the proportions of each clone in a sample t. Clonal fractions
for a sample t are modelled with a symmetric Dirichlet distribution with
hyperparameter γt:
(2.5) f·t | γt ∼ Dirichlet(γt)
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Fig 3. The full graphical model of Cloe.
Likelihood. Genotypes and clonal fractions come together in an admixture,
their dot product representing the expected allele fractions for each muta-
tion in each sample. We model mutant reads as successful trials from a
beta-binomial distribution with overdispersion parameter s. The probabil-
ity of success is a function of the expected allele fraction pjt =
1
2 (zj· · f·t).
To capture sequencing noise at extreme values of pjt we replace it with a
function e(pjt) that depends on the sequencing error rate ε (e.g. 0.1%) such
that
(2.6) e(pjt) =

ε if pjt = 0
1− ε if pjt = 1
pjt otherwise.
The likelihood is then specified by
(2.7) xjt | djt, zj·, f·t, s ∼ Beta-binomial(djt, e(pjt), s).
Nuisance parameters. We let the beta-binomial overdispersion parameter
s and the Dirichlet hyperparameters γ have Gamma priors, whereas the
mutation and reversion probabilities µ and ρ are fixed.
2.2. Penalising convergent evolution. One of the risks of assuming the
independence of features in this biological application is that the inferred
genotypes may largely display convergent evolution. We can penalise such
occurrences by altering the definition of genotypes (cfr. equations 2.3 and
2.4).
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Under the infinite sites assumption (ISA) every mutation occurs only
once, so that if multiple clones possess a mutation j, then the mutation
must have appeared with their most recent common ancestor. In contrast, if
the most recent common ancestor is not mutated, then the mutation must
have appeared multiple times (convergent evolution). We thus say that a
mutation assignment zjk = 1 conflicts with ISA if the most recent common
ancestor of
{
k′ : zjk′ = 1, k′ ≤ k
}
does not harbour mutation j.
We include ISA checks into our model by using an indicator function
I(j, k, a) that returns 1 if the most recent common ancestor of all clones
k′ ≤ k that harbour mutation j also possesses the mutation, when zjk = a.
That is, I(j, k, a) = 1 if ISA is satisfied by setting zjk = a, and 0 otherwise.
Thus we redefine the distribution of genotypes making them conditional
on all previous genotypes and weighting assignments by a user-defined pa-
rameter ν if they comply with ISA, or by 1− ν if they do not:
(2.8) P (zjk = 1 | T ,Zj,<k, zjTk = 0, µ, ρ, ν) ∝ (µν)I(j,k,1)(µ(1− ν))1−I(j,k,1)
In practice, only transitions that gain a mutation can clash with ISA, and the
factor of ν immediately cancels out if the parental genotype is 1 at a given
j. An ISA-check at j is thus only warranted if the parent is not mutated at
j.
The graphical model corresponding to what has been described so far is
shown in Figure 3.
2.3. Inference. We are interested in the posterior distribution of the la-
tent variables given the observed variables P (T ,Z,F |X,D), which we ex-
plore by Metropolis-coupled Markov chain Monte Carlo (MCMCMC) [9],
integrating out the nuisance parameters s and γ. We use Gibbs sampling
to update the tree vector T and Metropolis-Hastings moves to update the
other quantities.
Because the posterior landscape appears composed of high peaks sepa-
rated by deep valleys (Supplementary Figure 1), we run five chains in par-
allel, with tempered posteriors. The sampling strategy described hereafter
is applied to each chain, and summarised in Algorithm 1.
Phylogeny. For each Tk>2, we compute the conditional posterior of the
parent assignment Tk = l, for each l < k:
(2.9) P (Tk = l | . . . ) ∝ P (Z | T−k, Tk = l)P (Tk = l)
The likelihood term amounts to tallying the genotype transitions from par-
ent l to child k, and reassessing how many transitions comply or clash with
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Algorithm 1 MCMCMC sampling algorithm for Cloe
1: for i = 1, . . . , #iterations do
2: for m = 1, . . . , #chains do
3: for j = 1 . . . J do . Z
4: Propose new z
∗(m)
j·
5: Accept with probability 2.12
6: end for
7: for k = 3 . . .K do . T
8: Compute P (T ∗(m)k = l) for l ∈ {1 . . . k − 1} (eq. 2.9)
9: Sample new T ∗(m)k from P (T ∗(m)k )
10: end for
11: Randomly swap two siblings
12: With probability 1% propose a swap between a node and its parent
13: Accept with probability 2.11
14: for t = 1 . . .T do . F
15: Propose new f
∗(m)
·t from eq. 2.13
16: Accept with probability 2.14
17: end for . Nuisance parameters
18: Propose new s∗(m) ∼ N (s(m), σs) and accept with probability 2.15
19: for t = 1 . . .T do
20: Propose new γ
∗(m)
t ∼ N (γ(m)t , σγ) and accept with probability 2.16
21: end for
22: end for
23: if i is a multiple of 100 then . Chain swap
24: Propose a chain j ∈ {1 . . .m− 1}
25: Accept the state swap between chains j and j + 1 with probability 2.17
26: end if
27: end for
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ISA for all clones. The prior, according to eq. 2.1, is equal to
(2.10)
P (Tk = l) = δI(l=1)
(
1− δ
k − 2
)1−I(l=1)
=
(
1
2k
)I(l=1) ( 2k − 1
2k (k − 2)
)1−I(l=1)
To facilitate the exploration of the space of tree and genotypes configura-
tions, we uniformly propose a pair of siblings and swap their position in the
tree and in the genotypes and clonal fractions matrices. Prior to this swap,
the siblings had access to one linear topology. This move allows the other
linear topology to be explored, while leaving probabilities unaltered.
In addition, the swap between a node k and its parent l is proposed. A
node k is chosen uniformly from {3 . . .K}. A tree T ∗ is created where k
is the parent of l, while any children of k remain children of k; the same
applies to l. As with the sibling swap, this move requires rearranging the
clone order in the genotypes and clonal fractions matrices. The parent swap
affects genotype transitions from Tl, the original parent of l, to k, and from
k to l. The proposal is accepted with probability
(2.11) min
(
1,
P (Z{Tl,k,l} | T ∗, µ, ρ, ν)P (T ∗{Tl,k,l})
P (Z{Tl,k,l} | T , µ, ρ, ν)P (T{Tl,k,l})
)
We perform this update with probability 0.01.
Genotypes. Because mutations are independent, we update Z by row, propos-
ing a new row z∗j· by flipping each bit of zj· with probability θ. The proposal
is symmetric and the move is accepted with probability
(2.12) min
(
1,
P (xj· |dj·, z∗j·,F, s)P (z∗j· | T , µ, ρ, ν)
P (xj· |dj·, zj·,F, s)P (zj· | T , µ, ρ, ν)
)
where the likelihood is only computed for mutation j, and the prior refers to
the sequence of transitions from the root genotype at j to the leaves, with
appropriate penalties for convergent evolution.
Clonal fractions. Because of the independence of the samples, the matrix
F is updated by column. A new vector f∗·t is proposed from a Dirichlet
distribution centred at the current value f·t:
(2.13) Q(f∗·t | f·t) = Dirichlet(ψ f·t + )
where ψ is a precision factor and  a small bias to avoid sinks at 0. The
proposal is accepted with probability
(2.14) min
(
1,
P (x·t |d·t,Z, f∗·t, s) P (f∗·t | γt) Q(f·t | f∗·t)
P (x·t |d·t,Z, f·t, s) P (f·t | γt) Q(f∗·t | f·t)
)
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Nuisance parameters. The remaining parameters are updated with Metropo-
lis moves using Gaussian proposals. The Metropolis-Hastings acceptance ra-
tios are
(2.15) min
(
1,
P (X |D,Z,F, s∗) P (s∗)
P (X |D,Z,F, s) P (s)
)
for s,
and
(2.16) min
(
1,
P (f·t | γ∗t ) P (γ∗t )
P (f·t | γt) P (γt)
)
for γt.
Temperatures and chain swaps. Regularly at user-defined intervals, a swap
between two adjacent chains is proposed as a Metropolis-Hastings move [9].
Let M denote the number of parallel chains, P (m) denote the tempered
posterior of chain m, and ωm denote the state of chain m. A chain m is
selected among the first M − 1 chains. The swap between chains m and
m+ 1 is then accepted with probability
(2.17) min
(
1,
P (m)(ωm+1) P
(m+1)(ωm)
P (m)(ωm) P (m+1)(ωm+1)
)
.
The temperature τm for each chain m is chosen according to the following
scheme:
(2.18) τm = (1 + ∆T (m− 1))−1
where ∆T > 0 regulates the temperature differences between chains.
Parameter estimates. MCMCMC parameter estimates are derived solely
from the first, untempered chain. After discarding a certain proportion of
the initial samples as burn-in, and thinning the chain by a factor of i, thus
considering every ith sample, we obtain a maximum a posteriori (MAP)
estimate of the parameters by selecting the chain state of the sample with
the highest posterior value.
3. Validation and benchmarks. We extensively validated and bench-
marked Cloe by using simulated data and a controlled experimental set-up
based on mixing cell lines.
3.1. Simulated data. We first tested our model on 9 simulated datasets,
one for each combination of number of clones (3, 4 or 5) and depth of se-
quencing (means: 50×, 200×, 1000×). The genotypes were created according
to a random tree and using parameters µ = 0.5, ρ = 0.05, ν = 0.9; clonal
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fractions were iid draws from a symmetric Dirichlet distribution with param-
eter γ = 2. All datasets contained 100 mutations and 5 samples, with depths
obtained from a Poisson distribution and mutant read counts obtained from
a binomial distribution. Because of the fixed size of our model, we ran Cloe
for 3, 4, and 5 clones on each of the 9 datasets (running parameters are
reported in Table 2).
We measured Cloe’s performance in several ways: we evaluated its ability
to identify the right number of clones, we assessed mixing by computing the
Gelman-Rubin statistic from three consecutive runs of the algorithm, and
finally we measured the reconstruction error. To perform the latter step, we
calculated two metrics, the normalised genotypes error Zerr and the nor-
malised clonal fractions error Ferr, both defined as the sum of the absolute
differences between inferred (Z∗) and the real (Z) matrices, normalised by
the real matrix dimensions (ignoring the fixed genotype in Z). To control
for equivalent solutions with permuted clones, we used permutations σ of
the columns of Z∗ to minimise Zerr:
(3.1) Zerr =
1
J(K − 1) minσ
∑
j,k
|z∗jσ(k) − zjk|
 ,
The same permutation is then used to rearrange the rows of F∗, which is
normalised by JK. If the real and inferred matrices have different sizes, we
pad the smaller one with normal clones with zero clonal fractions. In this
instance K refers to the real number of clones.
MCMC mixing and effective sample size. The Gelman–Rubin statistic was
calculated from the log-posterior values of the untempered chains as a proxy
for the multidimensional parameters. In every case, the potential scale re-
duction factor is within the accepted range, less than 1.1 (Figure 4). Each
run was started with a different random seed.
We computed the effective sample size (ESS) for the first run on each
dataset, focussing on the cases where the sought number of clones matched
the real number of clones of the dataset. Table 1 reports the ESS of the nui-
sance parameters and the log-posterior computed from 10,000 post-thinning
iterations. Modulating the standard deviation of the Gaussian proposals for
the nuisance parameters could decrease their autocorrelation. However, the
shape of the posterior space (Supplementary Figure 1) may prevent efficient
large moves.
Model selection. As a model selection criterion we used the log-posterior
probability of the MAP sample. We were able to recover the correct size
K for every dataset (Figure 5, left) in two of the three runs. In one run,
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Fig 4. The Gelman-Rubin statistic computed from three runs of our algorithm on the
simulated datasets. Row names consist of the number of clones that was used in the run,
and the characteristics of the dataset (sequencing depth and the real number of clones).
Dataset γ1 γ2 γ3 γ4 γ5 s LP
50x, 3 194.63 272.20 474.59 117.33 134.96 1696.31 4366.40
200x, 3 178.25 352.60 505.93 171.06 151.80 890.28 3088.45
1000x, 3 143.95 442.33 446.48 220.48 153.46 426.54 1685.87
50x, 4 648.35 241.09 586.84 170.57 342.17 1345.90 2323.20
200x, 4 735.31 195.13 683.51 152.63 346.05 1025.92 1700.03
1000x, 4 1083.17 302.75 654.13 140.00 237.40 406.45 894.08
50x, 5 395.45 239.42 209.06 261.33 369.81 1182.60 1673.17
200x, 5 803.71 387.01 394.54 324.07 644.47 947.42 2401.41
1000x, 5 990.07 401.38 373.32 284.74 657.88 478.26 1805.82
Table 1
Effective sample size per dataset. The effective sample size was computed on the 10,000
post-thinning iterations for the first of the three replicate runs with the correct number of
clones. The dataset is denoted by the average sequencing depth and the real number of
clones. LP denotes the log-posterior, as a proxy for the multidimensional parameters.
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Fig 5. Results on the simulated datasets. Left: inferred model size for every combinations
of K and depths. Centre and right: reconstruction errors. All datasets consisted of five
samples and 100 mutations.
a higher log-posterior probability was given to the solution with 4 clones
on the dataset with 50× and 5 clones (-14464.05 compared to the 5-clone
solution’s -14464.58; Supplementary Figure 2). In such cases, where the log-
posterior probabilities of different models are approximately equal, we prefer
the solution with higher log-likelihood value.
Reconstruction fidelity. To assess our reconstructions we considered only
the MAP solution for each dataset. The reconstruction error was low, with
Zerr ≤ 0.027 and Ferr ≤ 0.033. The largest errors were obtained at the
lowest depth (Figure 5, centre and right), suggesting that on these random
datasets Cloe can not only discover the correct number of clones, but also
infer correct genotypes and clonal fractions with > 96.7% accuracy (Supple-
mentary Figures 3 and 4).
Conclusion. This validation with synthetic data provided proof that the
model and the inference are sound, achieving good reconstructions even
with several clones and low sequencing depth (Supplementary Figure 5).
3.2. Controlled experimental data. Because synthetic data may not cap-
ture the variability seen in real biological data, we tested our method on
a bespoke experiment. In order to mimic heterogeneous tumour samples,
we genotyped five cell lines and mixed them together at known propor-
tions. Four single-cell-diluted cancer cell lines (HD124, HD212, HD249, and
HD659, from Horizon Discovery, UK) were mixed with a normal cell line
(HG00131, 1000 Genomes Project, Coriell Institute, USA). All five cell lines
were subjected to whole-exome sequencing (Nextera Rapid Capture Exome,
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Parameter Value
MCMCMC
iterations 40000
chains 5
∆T 0.4
swap interval 50
burn-in 50%
thinning factor 4
Z
µ 0.3
ρ 0.1
ν 0.75
θ (proposal) 0.20
ε (likelihood) 0.005, 0.002
F
ψ (proposal) 200
 (proposal) 4
Nuisance parameters
γ (prior, shape) 2
γ (prior, rate) 1
σγ (proposal) 0.2
s (prior, shape) 11
s (prior, rate) 0.10
σs (proposal) 16
Table 2
Running parameters for the simulated and validation datasets. For ε, the sequencing error
parameter, the first value refers to the simulations, the second to the validation dataset.
16 F. MARASS ET AL.
N
C1
C2 C3
C4
0.0
0.2
0.4
M1 M2 M3 M4 M5 M6 M7 M8 M9 M1
0
M1
1
M1
2
M1
3
M1
4
Samples
Al
lel
e 
fra
cti
on
Fig 6. The observed data for the validation dataset. On the left is the artificial phylogeny,
where N denotes the normal clone, C1 to C4 are the cancer cell lines, playing in this context
the role of clones. On the right are the observed mutational dynamics (allele fractions over
samples) at an average depth of 17260×.
Illumina, USA). Mutational and single nucleotide polymorphism (SNP) pro-
files were obtained using the standard samtools workflow [20]. To identify
copy-number neutral regions, we generated copy-number profiles with the R
package CopywriteR (version 2.2.0). We created 14 mixtures, with a median
tumour cellularity of 64% (Table 3).
Because the cell lines were unrelated, we selected a subset of mutations
(heterozygous single nucleotide variants and small indels) so as to embed
the cell lines into an artificial phylogeny (Figure 6, left). We focussed on re-
gions that were copy-number neutral across all cell lines, and measured allele
fractions by targeted sequencing (Figure 6, right) [7]. We excluded from the
final dataset mutations whose genotypes had been erroneously inferred from
exome sequencing data. The final dataset included 82 mutations, of which
one displayed convergent evolution and two were reversions to wildtype, and
was sequenced to a median of 17260× coverage. Targeted sequencing data
were processed with an in house pipeline and the known mutations were
quantified from pileups with a base quality cutoff of 30.
The large number of samples and the high depth of sequencing that we
obtained afforded a sensitivity analysis, in which we varied the number of
samples and the depth. Cloe was run on these datasets with the same pa-
rameters as for the synthetic data (Table 2).
Model selection. We ran Cloe for K ∈ {3, 4, 5, 6} and performed model se-
lection based on the log-posterior values of the MAP estimates. In every case
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M1 M2 M3 M4 M5 M6 M7 M8 M9 M10 M11 M12 M13 M14
N 0.26 0.34 0.22 0.13 0.37 0.38 0.72 0.26 0.13 0.45 0.65 0.38 0.53 0.00
C1 0.03 0.41 0.14 0.29 0.14 0.14 0.04 0.38 0.03 0.02 0.06 0.09 0.19 0.08
C2 0.18 0.00 0.19 0.25 0.06 0.04 0.11 0.05 0.32 0.18 0.03 0.28 0.00 0.30
C3 0.44 0.19 0.00 0.17 0.10 0.41 0.13 0.18 0.43 0.23 0.20 0.25 0.22 0.57
C4 0.10 0.05 0.44 0.15 0.33 0.05 0.00 0.14 0.10 0.12 0.07 0.00 0.06 0.04
Table 3
Clonal fractions in the 14 mixtures of the validation experiment.
we were able to identify the correct number of clones (Figure 7), suggest-
ing that either a moderate depth of sequencing or multiple samples should
suffice in obtaining good estimates of the number of clones.
Reconstruction fidelity. Overall, we obtained precise reconstructions for al-
most all depth-samples combinations. Considering for each combination only
the first solution suggested by Cloe, on average 1% of mutation assignments
were inaccurate (Zerr median 0, mean 0.013), and clonal fractions were in-
ferred with an average error lower than 2% (Ferr median 0.017, mean 0.019).
As expected, we observed a pattern of decreasing errors as the data increase
in the number of samples or in depth (Figure 8).
Specific low-depth cases. Poorer reconstructions were obtained at lower
depths (≤ 60×) for the datasets with three samples. In every case, the in-
ferred genotypes showed a faulty separation between two expected genotypes
(Supplementary Figure 6), which led to high error metrics: Zerr ≤ 0.134 and
Ferr ≤ 0.065. Despite the imprecise reconstruction, there is an overall good
agreement with the observed data (Supplementary Figure 6 (e)).
These results could be improved by tuning the running parameters of Cloe
for these datasets. Because the height of the posterior peaks at these levels
of depth is lower than at high depth, using less tempered chains may result
in higher acceptance of chain swaps, and, consequently, in a more complete
exploration of the posterior space. Increasing the number of MCMCMC
iterations could also prove beneficial.
It should be also noted that at low depths sampling noise may promote
suboptimal parameter combinations to near-optimal. In this case, more mu-
tations should be analysed in order to average sampling noise effects, though
this may place a heavy burden on our implementation’s runtime. Alterna-
tively, one could model more data in terms of samples. If the clonal fractions
are dynamic enough, meaning that most clones grow and shrink at some
point in the samples, more opportunities are provided to separate clonal
signals.
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Fig 7. Inferred model size K for every combination of samples and depths in the validation
dataset. The validation data consist of a mixture of five clones. Only the top solution was
considered in each case.
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Fig 9. Comparison of Cloe against three published methods on our validation dataset,
consisting of targeted sequencing for 82 mutations in 14 samples (average depth 17260×);
five clones are present in the data. Zerr denotes the reconstruction error on genotypes;
Ferr the error on clonal fractions. The two datasets (17260× depth and 14 samples, and
100× and 3 samples) are denoted “high” and “low”, respectively. The legend refers to the
number of inferred clones.
3.3. Comparison to previous approaches. To further benchmark Cloe, we
compared the results of three published methods compatible with targeted
sequencing on our validation dataset: BayClone [23] and Clomial [26], two
latent feature models, and PyClone [19], a non-parametric model. Other
methods, like PhyloWGS [3] or CloneHD [6], are not applicable to targeted
sequencing.
We ran two tests on the validation dataset described in the last section,
first using all samples and the entire depth, and then 3 samples and a depth
of 100×. Our method’s performance on the first dataset is a perfect recon-
struction of the genotypes (Zerr = 0) and a near-perfect reconstruction of
the clonal fractions (Ferr = 0.005), with a correct identification of the num-
ber of clones. With less data, there are three misassignment (Zerr = 0.009)
and the error of the clonal fractions is 0.017 (Figure 9); again, the number
of clones is correctly inferred.
BayClone [13] was run with default parameters for 45000 iterations, dis-
carding the first 5000 and thinning the chain by a factor of 4. We tested the
same model sizes as for our own method, namely 3, 4, 5, and 6. Through
the log-pseudo-marginal likelihood, BayClone was able to identify K = 5
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as the best solution on the first dataset. However, the reconstruction of the
genotypes was less precise (Figure 10), with Zerr = 0.25 and Ferr = 0.103.
Here Zerr, the normalised absolute difference between inferred and real geno-
types matrices, ignores the ploidy of the mutation. The reconstruction was
poorer on the second dataset because of the less precise data: six clones were
inferred with Zerr = 0.287, and Ferr = 0.147 (Supplementary Figure 7).
Clomial (version 1.6.0) implements an EM algorithm, and it was run with
default parameters (1000 restarts, and 100 maximum EM iterations) using
model sizes of 3, 4, 5, and 6. On the first dataset, model selection with BIC
(and AIC) indicated K = 5 as the best solution, with one misassignment
(Zerr = 0.003) and an accurate reconstruction of the clonal fractions (Ferr =
0.006). With less data, model selection was unclear as AIC, BIC and the
log-likelihoods were all discordant. Using the correct model size Clomial
obtained a Zerr = 0.076 and Ferr = 0.044.
PyClone (version 0.12.9) was run for 30000 iterations with a beta-binomial
density and copy-number neutral states allowing a single mutant allele out
of two (AB mode). PyClone was also provided with estimates of cellularity
for each of the samples. We removed the first 3000 iterations as burn-in
samples and thinned the chain by a factor of 4. The output of PyClone
consists of a clustering of the observed mutations, where each cluster should
roughly correspond to one of the non-root nodes of Figure 6. Phylogenetic
modelling can translate these clusters into genotypes. On the full dataset,
PyClone produced three clusters, as shown in Figure 10. Because the cluster
of stem mutations was merged with one of its two children, we were unable to
interpret the results phylogenetically. Hence, we could not derive genotypes
nor clonal fractions. The estimate of K is 4 with Zerr = 0.241. On less
data, two clusters were produced, leading to an estimate of K of 3, with
Zerr = 0.357.
In summary, our benchmark shows that Cloe compares favourably against
similar published methods (Figure 10). It is expected that the accuracy of
the reconstruction would be affected by the quality of the data. Indeed
every model performed more poorly on less data, however Cloe seemed to
be affected to a lesser extent (Supplementary Figure 7).
4. Case studies. We show the applicability of Cloe to clinical data in
two case studies.
4.1. Chronic lymphocytic leukaemia. This dataset consists of five time
points for each of three chronic lymphocytic leukaemia patients [21]. The
original study identified mutations by whole-genome sequencing (WGS; av-
erage depth across the mutation loci 39×) and quantified a subset of these
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Fig 10. Comparison of the genotypes inferred by the four benchmarked methods using all
the data in our validation dataset. PyClone’s reconstruction is a clustering of the muta-
tions. In this representation of the genotypes we padded solutions with the normal clone
(C1) for a more direct comparison with our method. The legend refers to the proportion
of mutated alleles out of two.
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with deep targeted sequencing (TAR; average depth 101600×).
The authors’ analysis reported evolutionary trees and clonal fractions for
each of the three cases. We used this information to run Cloe with known
clonal fractions on all mutations, prioritising information from the higher
depth datasets. We interpreted these results as ground truth mutation as-
signments for all three patients, and scored our reconstructions to these
reference parameters.
We ran Cloe on the reported mutations with K ∈ {3 . . . 7} for each case
and each experiment (WGS, low-depth, and TAR, high-depth), comparing
our results with the original study, with PhyloSub’s results [14], and with
CloneHD’s reconstruction of case CLL003 [6]. We also included another
dataset, which consisted of the WGS dataset with data from the higher
depth TAR dataset for mutations in common.
Case CLL003 displays a radical clonal shift (Supplementary Figure 8 (a)
and (b)): the main clone in the early time points is replaced by a distinct new
clone that appears only at the second time point and expands to become the
predominant clone. Using targeted sequencing data, Cloe obtained a very
accurate reconstruction, identifying the correct number of clones, obtaining a
single misassignment and average errors on clonal fractions of 1% (Figure 11,
Supplementary Figure 9). On less data, our method opted for a solution
with 4 clones that ignored the founding clone, only present in the first of
five samples at a clonal fraction of 3%. Choosing the top solution with 5
clones recovered the correct clonal structure; on WGS data there were five
incorrect mutation assignments (Supplementary Figure 10), whereas with
the combined dataset only one (Supplementary Figure 11). Barring the rare
founding clone, the 4-clone reconstructions are correct with one (combined
data) and two (WGS data) misassignments.
The remaining cases showed more stable dynamics (Supplementary Figure
8 (c)–(f)). For CLL006, Cloe assigned the nine mutations of the TAR dataset
to six clones without errors; three errors were observed with 18 mutations in
the WGS dataset (Figure 11). Analysis of the combination of the two data
types yielded an additional clone, though similar log-posterior probabilities
and a higher log-likelihood were obtained by a six-clone solution. Remov-
ing clone C5 from the seven-clone solution yields a correct reconstruction
(Supplementary Figure 12).
Finally, for CLL077, Cloe’s analysis resulted in a perfect reconstruction
of the genotypes with targeted sequencing data. Two misassignments were
obtained for the combined dataset, whereas four of the five clones were
identified in the WGS data: the founding clone, with only four of the 20 mu-
tations, was merged with one of its children. After the four-clone solutions,
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Fig 11. Performance metrics of Cloe on the CLL datasets. The correct number of clones
for cases CLL003 and CLL077 is 5, whereas for CLL006 it is 6. TAR stands for targeted
sequencing (average depth 101600×); WGS stands for whole-genome sequencing (average
depth 39×; BOTH is the WGS dataset with TAR data for shared mutations. The legend
refers to the number of inferred clones. When the first solution inferred the wrong number
of clones, the top solution for the correct number of clones is also shown.
solutions with six-clones had high log-posterior probabilities. Indeed the first
of these solutions is an accurate reconstruction with two misassignments and
one clone repeated twice almost identically. In the middle, solutions with the
expected number of clones, five, had six errors (Supplementary Figure 13).
Overall, Cloe produced accurate reconstructions of the latent parameters.
Higher errors were observed when an incorrect number of clones was inferred.
However, even in these cases, our phylogenetic model allowed us to obtain
close approximations of the ground truth.
Assuming that our reconstruction of the ground truth is correct, Cloe’s
inference results in a better reconstruction than reported by CloneHD [6],
both using high-depth and low-depth data: first, because of our phylogenetic
modelling, we were able to identify the founding clone; second, we could
confidently identify the rising clone’s parent (the ambiguous green clone in
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[6]). With low-depth data, Cloe did prefer a model with four clones, but
could also provide a more accurate five-clone solution.
Our results on targeted sequencing data largely agree with those obtained
by PhyloSub [14], with two small exceptions. For CLL003, Cloe predicts
that clone 4 (clone c in [14], Figure 7, right) does not harbour the IL11RA
mutation. This episode appears to be supported by the data (Supplementary
Figure 14) as Cloe’s reconstruction leads to closer fit with the data (sum of
absolute errors on the allele fractions is 0.06 for Cloe, 0.13 for PhyloSub,
for this mutation). Rather than a loss of mutation, this could be due to
convergent evolution at the leaf nodes, leading to a sum of absolute errors
of 0.07. For case CLL006, our reconstruction agrees with that of [21]: five
tumour clones are detected, and the EGFR mutation is predicted to stem
from the founding clone. PhyloSub preferred to place the EGFR mutation
in an additional clone after the founder, leading to a closer fit: the sum of
absolute errors was 0.02 compared to Cloe’s 0.07 for this mutation.
4.2. Acute myeloid leukaemia. AML31 refers to a patient with acute
myeloid leukaemia, whose case was studied in great depth with several se-
quencing experiments targeting bulk DNA at various scales, RNA and also
single cells [11]. As each layer of data refined the authors’ understanding
of the evolution of this tumour, seven clusters and driver mutations were
identified. Integration of all sequencing data revealed over 1300 mutations
curated in a “platinum list”. The tumour genomes appeared to be devoid of
copy-number aberrations.
We considered a subset of platinum-list mutations for three datasets:
ALLDNA (median depth of 1841× for the primary tumour sample, 388× for
the relapse), TORRENT (median depths 41× and 46.5×), and WGS (me-
dian depths 323× and 41×). For each dataset, we selected a random subset
of 250 mutations, halving the number of mutant reads for hemizygous mu-
tations, and adding reported driver mutations.
Cloe was run with K ∈ {3, . . . , 7} on the datasets. Model selection on
ALLDNA indicated K = 5 as the preferred solution, followed closely by
K = 6 which provided a closer fit to the data (Supplementary figure 15).
The inferred mutation dynamics for both models are shown in Figure 12.
Whereas both model sizes could capture the trends in the data, the solution
for K = 6 correctly identified two groups of mutations that rise in allele
fraction in the relapse sample.
Our reconstruction shows a decrease in tumour burden at relapse, a single
origin for all clones, and branched evolution after the founding clone (Fig-
ure 13). Clone 5 and its child, clone 6, become the main clones in the relapse
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Fig 12. Observed and inferred mutation dynamics for 257 mutations from the ALLDNA
dataset. Left: observed allele fractions; centre: allele fractions inferred by Cloe with 5
clones; right: allele fractions inferred by Cloe with 6 clones.
sample, supplanting clones 3 and 4. The founding clone appears present only
at very low clonal fractions.
Matching our clones to the original clusters, we found a close correspon-
dence (Table 4), corroborating Cloe’s inference. The only misassignment is
TP53 to clone 6, which in the original study required single-cell sequenc-
ing and additional time points to identify as belonging to a separate clone.
Beyond the genotypes, there was also a close match between inferred and
expected clonal fractions, with a maximum absolute difference of 4%.
Cluster 6 was not identified by our model. According to the original anal-
ysis, this cluster was present at less than 5.5% clonal fraction in the primary
sample, to then disappear at relapse. Such a cluster would contribute half
of its clonal fraction in allele fraction, due to the heterozygosity of the mu-
tations. We do observe that nine of the 257 mutations were not assigned to
any clone. Their average allele fraction was 2.2% in the primary sample and
close to 0% in the relapse (Supplementary Figure 16). Because they did not
fit the dynamics of the other clones, sequencing noise was used to fit them
(eq. 2.6).
On the modest amount of data of the TORRENT dataset our model
selection produced a more conservative estimate of the number of clones,
preferring four clones. Using five or more clones improved the log-likelihood
to the same extent. We compare here solutions for K = 4 and K = 5
(Figure 14).
With three tumour clones, our model matched the main trends: two large
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Fig 13. Parameters inferred by Cloe running with 6 clones on 257 mutations from the
ALLDNA dataset. Genotypes are shown on the left, where green denotes presence of a
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Clone Cluster Drivers
C2 1 DNMT3A
C4 4 FOXP1
C5 3 IDH2
C3 2 IDH1
C6 5 CXCL17, TP53
Table 4
Correspondence between Cloe’s inferred clones, and the clusters in the original analysis
by [11]. While drivers are also present in the children of a clone, here we report the clone
in which the mutations first appeared.
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Fig 14. Observed and inferred mutation dynamics for 254 mutations from the TORRENT
dataset. Left: observed allele fractions; centre: allele fractions inferred by Cloe with 4
clones; right: allele fractions inferred by Cloe with 5 clones.
clones in the primary sample that disappear at relapse, and one growing
clone. In addition, tumour content was accurately inferred: 89% for the
primary sample and 44% for the relapse sample, compared to the expected
values of 91% and 47%. The addition of a fourth tumour clone (K = 5) allows
a better disambiguation of the clones present in the primary, while the spread
of allele fractions in the relapse sample makes it difficult to distinguish two
rising clone.
Identifying seven clones including the normal in two samples with a me-
dian depth less than 45× is an arduous task. [11] show that SciClone detects
four clones up to around 100× depth using all mutations on the platinum
list. While Cloe prefers four clones using a subset of mutations at a depth
of 45×, it is capable of splitting the observed dynamics further, obtaining
closer approximations of the real clonal structure.
Finally, for the WGS dataset, Cloe’s solution with 5 clones obtained the
highest posterior probability, while 6 and 7 clones obtained closer fits to the
data (Supplementary Figure 17). With four tumour clones, Cloe identified
three decreasing groups of mutations and one group that arose at relapse.
This matches the observed dynamics, as the low depth at relapse accounts
for a larger spread of the allele fractions that confounds the identification of
two rising clones (Supplementary figure 18). Interestingly, the addition of an-
other clone, rather than fitting this low-depth relapse data, matches a fourth
group of mutations present only in the primary around 5% clonal fraction.
These mutations overlap with the unassigned mutations in the ALLDNA
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dataset and the inferred clone does not harbour additional driver mutations
other than DNMT3A, which derives from its parent.
With this case study we applied Cloe to a scenario with two samples,
highlighting the difficulties of automatic model selection, especially when
trying to identify a large number of clones with a moderate amount of data.
The running parameters for the two case studies differ from the ones listed
in Table 2 in that we used five chains with ∆T = 0.25. In addition, for the
AML datasets we ran 50000 iterations of our sampler with µ = 0.2, ρ = 0.04,
and ε = 0.001.
5. Discussion. As tumour sequencing data grow in depth and breadth,
the question of tumour heterogeneity will continue to be focal. In this study
we presented Cloe, a novel latent feature model for direct clonal recon-
struction. Our model discovers genotypes in the data by assigning observed
mutations to latent features (clones) guided by a latent phylogeny. This
phylogenetic deconvolution sets Cloe apart from other direct reconstruc-
tion methods [6, 26, 23]. Compared to indirect reconstruction methods, our
algorithm can handle multiple primary tumours, the loss of mutations and
convergent evolution. In particular, to our knowledge this is the first method
to allow and penalise convergent evolution.
Our study on simulated data showed a good performance of our MCM-
CMC algorithm. However, tuning the MCMCMC parameters in order to
correctly explore the spiked posterior landscape is not trivial. We empiri-
cally found parameters that would allow the chains to mix well. Regions of
high posterior probability are quickly reached, yet finding the right peak is a
slow process, complicated by each biological constraint on the model. Many
parameters can be tuned in our model. We sought values that would work
well for both simulated data and our validation data. Tuning the MCMCMC
parameters to each dataset independently, thus optimising the exploration
of the posterior space, might further improve results.
In our definition of the tree we assume that multiple primary tumours are
less likely to occur than tumours with a single origin. If our understanding of
clonal evolution were to suggest otherwise, the definition of the tree may be
simplified to a discrete uniform distribution, giving equal weight to a single
origin or multiple ones.
Limitations. The main limitation of our method is the restriction to mu-
tations from copy-number neutral regions. Whereas this may be amenable
to certain types of cancer (e.g. mutation-driven rather than copy-number
driven cancers), it may preclude the analysis of more genomically rearranged
tumours.
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In contrast to some models described in the literature, our method does
not include the number of clones as a parameter. Instead, Cloe must be
run for various choices of K, and the best solution in terms of posterior
probability will indicate the number of clones with good accuracy. On our
simulation and validation datasets our model was indeed able to identify the
correct number of clones in 58/59 cases.
As shown in the case studies, model selection may not be trivial. We thus
recommend manual review of the inferred parameters for various model sizes
to ensure that the results of the inference are robust.
Analysing hundreds of mutations can result in a high computational bur-
den. This limitation could be alleviated by preprocessing the input data,
grouping mutations that exhibit similar dynamics throughout the samples.
One way to do this is via a Chinese Restaurant Process with a product
of binomials; mutant read counts and depths for all mutations in a cluster
could then be summed and analysed as a single unit.
Extensions. We see several avenues for future extensions. At the theoreti-
cal level, future work should focus on optimising the inference and extending
this framework to arbitrary copy-numbers. Also, to address the model selec-
tion problem, the phylogenetic latent feature model could be rephrased in a
non-parametric perspective. In terms of applications, our model could also
be applied to epigenetics: by appropriately changing the likelihood func-
tion, Cloe could deconvolute methylation data into evolutionarily related
epigenotypes.
In summary, Cloe is a rigorous and flexible framework for clonal decon-
volution of cancer genomes that achieves high accuracy in benchmarking
studies and leads to important insights into tumour evolution in clinical
case studies.
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SUPPLEMENTARY MATERIAL
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(./supplementary figures.pdf; .pdf). Supplementary figures.
Supplement B: Source code of the analyses
(./reproduce.tar.gz; .tar.gz). This package contains scripts, data (in the form
of matrices of mutant read counts and depths) analysed in this article, and
a version of Cloe to reproduce the findings.
Cancer Research UK Cambridge Institute
University of Cambridge
Li Ka Shing Centre
Robinson Way
Cambridge, CB2 0RE
United Kingdom
E-mail: francesco.marass@cruk.cam.ac.uk
florian.markowetz@cruk.cam.ac.uk
